| Literature DB >> 32923407 |
Joshua Seun Olajide1,2, Jianping Cai1.
Abstract
Extracellular vesicles (EVs) are membranous structures formed during biological processes in living organisms. For protozoan parasites, secretion of EVs can occur directly from the parasite organellar compartments and through parasite-infected or antigen-stimulated host cells in response to in vitro and in vivo physiological stressors. These secreted EVs characteristically reflect the biochemical features of their parasitic origin and activating stimuli. Here, we review the species-specific morphology and integrity of parasitic protozoan EVs in concurrence with the origin, functions, and internalization process by recipient cells. The activating stimuli for the secretion of EVs in pathogenic protozoa are discoursed alongside their biomolecules and specific immune cell responses to protozoan parasite-derived EVs. We also present some insights on the intricate functions of EVs in the context of protozoan parasitism.Entities:
Keywords: effects; exosomes; extracellular vesicles; host cells; protozoa; stressor
Mesh:
Substances:
Year: 2020 PMID: 32923407 PMCID: PMC7456935 DOI: 10.3389/fcimb.2020.00371
Source DB: PubMed Journal: Front Cell Infect Microbiol ISSN: 2235-2988 Impact factor: 5.293
Preparation and description of pathogenic protozoan-derived Evs.
| Cytoplasmic vesicles EDG | Liver lesion/TYI-SS MD | ? | Plasma membrane, cytoplasm cell periphery | 0.1–1.0 μm | Cationic and actin proteins | Chavez-Munguia et al., | |
| EVs | Glucose MD | 2, 5 | ? | 31.9–467 nm | Serine protease, metalloproteinase, phospholipid, sterylesters, free fatty acids, | Gonçalves et al., | |
| Exosome-like vesicles | PYG MD/page's Neff's saline | 4,3,5 | ? | 166.7 nm | IUNH, carboxylic ester hydrolase, peroxidase, aminopeptdase | Lin et al., | |
| Microparticles | Parasitized RBCs | 1,5 | iRBCs | 150–250 nm | ? | Couper et al., | |
| Secretory vesicles | Ookinete medium | 1 | Anterior end of parasite | Pantothenate transporter | Kehrer et al., | ||
| EVs | 4,2,5,7 | infected RBCs | 100–400 nm | Ago2, miRNA | Mantel et al., | ||
| Exosome-like vesicles | CM 2–4% haematocrit | 1,6 | Maurer's cleft/infected RBCs | ~70 nm | PfPTP2, DNA | Regev-Rudzki et al., | |
| EVs | iRBCS | 4,2,7 | iRBCs | 50–350 nm | (ds) gDNA, tRNA, 5sRNA miRNA (hsa-miR-451a)+,mRNA, DNA-binding protein H3, H4 | Sisquella et al., | |
| Microvesicles | iRBCs | 4,2,7 | iRBCs | 100–250 nm | PVM, RESA, SBP1, Exp1, parasite invasion proteins | Mantel et al., | |
| Exosomes | Mice-infection | 4 | iReticulocytes | ~56.8 nm | serine-repeat antigen, MZ surface protein 1&9, protease hsps, enzymes | Martin-Jaular et al., | |
| EVs | Modified RPMI | 1,4,5 | Infected cell | ~100 | Glycophorine, CD63, PfMSP1, lactate dehydrogenase | Correa et al., | |
| Vesicles | RPMI, 2% Exo-FBS | 1,2,5 | Parasite surface | 50–150 nm | Functional proteins of ribos-omes, metabolism, RNA transport, hsp70&90, proteosome | Li et al., | |
| Exosomes | DMEM without serum | 2,8 | ? | 10–150 nm | hsp70,surface antigen 1 (SAG1) | Li et al., | |
| EVs | RPMI without FBS | 1,2,9 | Membrane sur-face of parasite | 138.2–171.9 nm | 15–70 kDa protein spectrum | Silva et al., | |
| EVs | FBS free DMEM | 1,2,8 | ? | 130.8 ± 3.7 nm | Celullar, interaction, metabo-lic, regulation, response protei | Wowk et al., | |
| Exosomes ectosomes | Sterile PBS at 37°C | 4,5 | Apical & posterrior end, PM | 50–200 nm | MIC, ROP, GRA, phosphatase, metabolic proteins | Ramírez-Flores et al., | |
| Vesicles | Acetate, NaCl CaCl2 | 4,5 | FP, PM evagination | 0.5 μm | Glycoproteins | Da Silveira et al., | |
| EVs | FBS free RPMI | 1,2,8 | 136.33 ± 86.3 nm | TcTASV-C secreted virulence factor | Caeiro et al., | ||
| Exosomal vesicles, TESA EVs | FBS free EMEM | 1,5,7 | PM | 60–100 nm | TESA, trans-sialidases, protease gp63, TolT, MASP, mucin-like protein TASV-C | Bautista-lópez et al., | |
| Vesicles, reservosomes golgi-like vesic | Serum free/1% FBS in RPMI | 4,5 | Golgi complex, cytostome, FP | 20–200 nm | TcPIWI-trypomastegote protein tsRNAs | Garcia-Silva et al., | |
| Vesicles | RPMI with 10% free-EV IFCS | 5 | Parasite surfa-ce, flagellum | 50–100 nm | Mucin, MASP with signal peptide (SP) | Lozano et al., | |
| Vesicles | RPMI with 5% glucose | 1,2,9 | membrane sur-face | ≤ 200 nm | Proteins and terminal α-galact-osyl residues | Nogueira et al., | |
| Vesicles, MVs, LVs | DMEM without FBS | 2,5 | PM, FP | 100–200 nm | Host-parasite interaction, signaling, transcription, hsps, chaperons, proteolytic proteins | Bayer-Santos et al., | |
| Vesicles | HBSS | 4,5 | Cell body, FP | 40–500 nm | Acid and alkaline phosphatases | Nievas et al., | |
| EVs | DMEM with 2% glucose | 1,2,10 | ? | 2–3 μm | Transsialidases. MASPs, gp63 tubulin, hsp, mucins, proteases | Ribeiro et al., | |
| EVs | FBS freeDMEM/TAU3AAG | 2,5 | ? | ? | rRNA, tRNA, CCD, snoRNA and snRNA | Bayer-Santos et al., | |
| Microvesicles | Secretion medium | 1,2,5 | PM, FP | 50–100 nm | Degradation, nucleotide metabolism, folding protein | Geiger et al., | |
| Nanotubules/EVs | RNAi-α-KDE1 complement active FBS, inaactvated serum | 2,5 | FP | 70–165 nm | vSG, hsp70, glycerol kinase, matrix glycosomes, mitochondrial membrane protein | Szempruch et al., | |
| Exosomes | Trans-splicing inhibition (Vp36 silencing) | 2,5,7 | FP, membrane nanotubules | 50–200 nm | SL RNA-associated proteins, p22, p27, and p58 | Eliaz et al., | |
| Vesicles | Miltefosine/apoptosis indicers, G418 | 5,3 | ? | 30–100 nm | gp63, ribosomal protein, hsp70 elongation factor-1α, beta tubulin, β-fructofuranosidases | Santarém et al., | |
| Microparticles, (Exosomes, vesicles) | Neutral and acidic medium | 4 | PM, FP, phagol ysosome | 30–70 nm | TESA, trans-sialidases, protease transport, metabolic protein | Silverman et al., | |
| Exosomes | RPMI with HEPES, MES | 4,2,7 | ? | ? | hsp100, 90, 70.4, gp63, histone, chaperonin proteins | Silverman et al., | |
| Exosome-like | Insect | 11 | Membrane sur | 50–120 nm | GP63, calpain-like cysteine peptida | Atayde et al., | |
| Vesicles | Gut | Face,FP, MVB | se, HSP70, tryparedoxin peroxidase surface antigen protein | ||||
| Exosome | RPMI pepton | 1,4 | ? | 122 ± 56 nm | HSP70, HSP83/90, | Castelli et al., | |
| Vesicles | Yeast | 115 ± 65 nm | Acetylcholinesterase | ||||
| Evs | RPMI/20% glucose | 2,4 | Whole body | 180 nm | gp63, LPG | Barbosa et al., | |
| Microvesicle-like structure | Serum free TYM with CaCl2 | 1,2,3 | PM, Flagellum | 100–1,000 nm | Metabolic enzymes, ribosomal, cytoskeletal, endoplasmin Memebrane vacoule proteins | Nievas et al., | |
| (B7RC2, G3, T1, RU38) | Exosome | TYM without serum | 2,5,7 | Large vesicular bodies | 50–100 nm | Small RNAs, tetraspanins, Alix, Rabs, hsp70, signaling and metabolic proteins | Twu et al., |
| Microvesicles | Serum free YiS with CaCl2 | 4,5 | Trophozoite | 201.4 nm | Nuclear, surface, cytoskeletal proteins, and chaperones | Evans-Osses et al., | |
1. Centrifugation 2. Filtration, 3. Concentration by ultrafiltration/high molecular weight cut-off filter 4. Sequential/serial centrifugation 5. Ultracentrifugation, 6. Buoyant density on Optirep gradient fractionation 7. Buoyant density on sucrose gradient fractionation 8. precipitation by exo-prep kit 9. Gel exclusion chromatography, 10. Size exclusion chromatography 11. Dissection/Suspension in PBS FP, flagellar pocket, PM, plasma membrane T, trypomastegote, E, emastegote A, amastegote,
putative, CM, culture medium; MD, medium; EDG, electron dense granules; IUNH, inosine-uridine- preferring nucleoside hydrolase family protein; SAG, surface antigen protein; MIC, microneme proteins; RESA, trypomastigote excreted-secreted antigens; SBP1, skeleton binding protein 1; PVM, Parasitophorous vacuole membrane protein; GRA, dense granule antigens; ROP, Rhoptry protein; TcTASV-C, T. cruzi Trypomastigote Alanine, Valine and Serine rich proteins; PFMSP1, P. falciparum merozoite surface protein.
Summary: Combining filtration/concentration and ultracentrifugation through sucrose gradient cushion retain intact membrane vesicles. Commercial exosome purification kit which could precipitate a wider or more restricted range of vesicles has also been used for PPEVs isolation but its validation requires categorical proof. Populations of vesicles obtained by differential centrifugation and ultracentrifugation, most often provides a mixed population of EVs (Colombo et al., .
Figure 1Functional Effects of PPEVs. After-effects of PPEV interaction and internalization by recipient cells and protozoan parasites. The common effects in parasites and host cells are seen in communication, development, and gene expression.
Figure 2Secretion and mechanisms of PPEVs internalization. PPEVs are formed after protozoan parasite exposure to various chemical and mechanical triggers in host cells, in vitro, and in the gut of vectors. After secretion, PPEVs are quickly taken up by susceptible cells, but various mechanisms have been proposed for internalization process. (A) bulk transport of PPEVs across the cell membrane via endocytic assimilation involving phagocytosis and pinocytosis. (B) PPEVs fuse with the host target cell before consequent internalization which may be mediated by Caveolin-dependent pathways. Lipid rafts, cholesterol, and lectin on PPEV membranes and host cells play significant roles in this respect. In the process of caveolin-dependent pathway, host cell caveolin-1 acts as regulator, and HSPGs acts as receptors for T. vaginalis EVs. Alternatively, using the mechanisms of membrane transporters, L. donovani exosomes could hijack the host retrograde trafficking pathway to directly dump exosomal cargo into the host cell (Garcia-Silva et al., 2014). (C) Possible uptake of PPEVs via receptor-ligand interactions involving receptors and proteins on host cells and membranes of PPEVs. Clathrin is a protein scaffolding found coating eukaryotic vesicles, which plays important role in receptor-mediated endocytosis of PPEVs through the plasma membrane associated with different adaptor proteins for clathrin-coated EVs. PPEV membrane protein can thus interact with receptors on the target cell and activate intracellular signaling. In this process, Rab5 protein mediates endocytosis and fusion of clathrin-coated vesicles. Also, GPI anchors on the vesicles may facilitate fusion to the host cell. Surface expression of vascular cell adhesion protein-1 (VCAM1) in endothelial cells has been demonstrated as a host cell response to iRBC EV uptake, which is significant in vascular dysfunction (Mantel et al., 2016). (D) Process by which immune cells interiorize PPEVs. A fundamental basis for PPEV internalization by immune cells has been linked to endocytosis and phagocytosis. There has been no empirical proof for ligand-receptor-mediated fusion and internalization of PPEVs by host immune cells. However, internalization of PPEVs by immune cells can redirect cytokine secretions and differential regulation of immune pathways.
Immune cell functional responses after interaction with PPEVs.
| keratitis | Ac EVs | Human | Increased IL-6 and IL-12 | Lin et al., | |
| Granulomatous amoebic | Monocytes | ||||
| Meningoencephalitis | |||||
| Malaria | Pf RMVs | PBMCs macrophage neutrophils | Upregulation of CD40, CD54, and CD86; decreased IL-10 IL-10 and TNF-α | Mantel et al., | |
| Pg MPs | Macrophage | Increased CD40 and TNF expression | Couper et al., | ||
| pf RMVs | Macrophage/PBMCs | Activation of IL-6, IL-12, IL-1β, and IL-10 | Mantel et al., | ||
| Pf EVs | Monocytes | mRNA induction of CCL5, of CCL5, CXCL10, IFNα, IFNB, IFIT1 | |||
| Neosporosis | Nc EVs | Macrophage | IL-12p40, TNF-α, IL-1β, IL-6 | Li et al., | |
| BMDMs | IFN-γ, and IL-10 increased | ||||
| Toxoplamosis | Tg exosome | Macrophage | IL-12, TNF-α and IFN-γ signicantly increased | Li et al., | |
| Tg EVs | Splenocytes | Significant high IFN-γ, IL-12; CD8+ subset of T cells | Li et al., | ||
| Tg EVs | Murine | mRNA expression of IL-10 | Li et al., | ||
| Macrophage | TNF-α, iNOS up-regulated | ||||
| Trypanosomiasis | Tc EVs | BMDMs | Decreased TNF-α IL-6, NO, | Lovo-Martins et al., | |
| Spleen cells | TNF-α,IL-6,IL-12p70, IFN-γ, MCP-1, IL-10 | ||||
| Murine | Induction of LB and PGE2 | ||||
| Macrophage | |||||
| Tc vesicles | Splenocytes, macrophages, B cell | higher TNF-α, IFN-γ, IL-6, IL-10, NO, IL-10 CD4+ and CD8+ | Nogueira et al., | ||
| DC | higher T lymphocytes, TNF-α | ||||
| Tc vesicles | Splenocytes | Higher IL-10 levels, not IL-4 and NO | Torrecilhas et al., | ||
| Mice heart | induced IL-10 and IL-4 mRNA | ||||
| Tc EVs | CHO/CD14 | lower IL-1β and higher IL-6 inductions, and TNF-α | Cronemberger-Andrade et al., | ||
| Leishamaniasis | Li exosome | DC macrophage | MHC-ll basal, decresed CD40 and CD 86 | Pérez-Cabezas et al., | |
| Ld exosomes | MoDCs | increased TNF-α, IL-6, IL-8 reduced CD80, CD86, HLA-DR increased IFN-γ, IL-10, IL-17 | Silverman et al., | ||
| Splenocytes | higher IFN-γ, IL-4(CD4)Tcells | ||||
| Spleen nymph node | lower IFN-γ (CD4 T cells) and Foxp3 | ||||
| Li exosomes | Human | Inducted IL-10 | Castelli et al., | ||
| Monocytes | Reduced IL-18 | ||||
| Lm exosomes | Lymph node | Inducted IL-17a, IL-4, IL-23, INF-y | Atayde et al., | ||
| La EVs | Macrophage | Increased IL-6, IL-10 | Barbosa et al., | ||
| B-1 cell | Increased IL-6, decreased IL-10 | ||||
| Trichomaniasis | Tv exosome | Macrophage | increase NO, IL-6, IL-8 IL-10, IL-17,IL-22 and TNF-α expression | Olmos-Ortiz et al., | |
| Giardiasis | Gi microvesicles | Dendritic cel | CD25, T cell alloproliferation | Evans-Osses et al., | |
PBMCs, peripheral blood mononuclear cells; Pg, P. berghei; Ac, A. castenallii; N. caninum; Tg, T. gondii; Tc, T. cruzi; Li L, infatum; Lm, L. major; La, L. amazonensis; Ld, L. donovani; Tv, T,vaginalis; Gi, G. intestinalis; DC, dendritic cell; MoDCs, momocyte derived DC; LB, lipid body; and PGE.
No change in expression level.